Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1OMALIZUMAB1件: Omalizumab1件: D05251 (Name: Omalizumab)1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299
2Omalizumab (Xolair)1件: Omalizumab1件: D05251 (Name: Omalizumab)1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 65
3Recombinant humanized monoclonal antibody omalizumab to IgE1件: Omalizumab1件: D05251 (Name: Omalizumab)1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299
4Rituximab combined with Omalizumab2件: Omalizumab,
Rituximab		2件: D02994 ,
D05251 (Name: Omalizumab)		2件: FCER1A,
MS4A1 💬		5件: Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 162